ah.novartis.comTiamutin home page

First choice therapy

First choice therapy against M. gallisepticum and M. synoviae in chickens

Mycoplasma gallisepticum (MG) MICs (minimum inhibitory concentration)

Tiamulin displays exceptional activity against MG in an overview by Hannan and others (1997) where 20 isolates were tested from the UK, Germany, Denmark, USA and Japan.
 

 
 

MICs of antimicrobial agents against field and type strains of MG (20 isolates)
MICs (µg/ml)
Antimicrobial
Type strain
Field strains
 
NCTC10115
Range
MIC 50%
MIC 90%
Enrofloxacin
0.01
0.025-1.0
0.05
0.1
Danofloxacin
0.005
0.01-0.5
0.05
0.1
Tylosin
0.01
0.0025-10.0
0.01
2.5
Oxytetracycline
0.1
0.05-0.5
0.25
0.5
Tiamutin® (tiamulin)
0.0025
0.0005-0.25
0.001
0.025

 
 

Tiamulin had extremely low MICs against MG with the MIC 50% being 0.001µg/ml and the MIC 90% at 0.025µg/ml.
 

The fluoroquinolones and oxytetracycline also showed a high level of activity but some strains of tylosin did show high MICs and evidence of resistance.

Mycoplasma synoviae (MS) MICs

Hannan and others (1997) compared the MICs of tiamulin against 28 isolates of MS from around the world and again showed tiamulin to be highly active.
 


 

MICs of antimicrobial agents against field and type strains of MS (28 isolates)
MICs (µg/ml)
Antimicrobial
Type strain
Field strains
 
NCTC10124
Range
MIC 50%
MIC 90%
Enrofloxacin
0.5
0.05-0.5
0.25
0.5
Danofloxacin
0.5
0.1-0.5
0.25
0.5
Tylosin
0.025
0.0025-50
0.025
50
Oxytetracycline
0.11
0.025->100
0.1
100
Tiamutin® (tiamulin)
0.1
0.05-0.5
0.1
0.25

 
 

All isolates would be considered sensitive to tiamulin with the MIC 50% at 0.1µg/ml and the MIC 90% at 0.25µg/ml as well as the fluoroquinolones. Definite resistance (very high MICs) could be observed with tylosin and oxytetracycline by their MIC 90%, although they would still be considered active at their MIC 50% level.

Tiamutin - first choice against mycoplasmas found in turkeys too

In a separate study (Valks and Burch, 2001), a search of published literature was carried out and these data were combined with Novartis’ own internal reports. A total of 20 references were compiled. Reports from 1975-1989 and from 1990-2000 were compared. The ranges of MICs of various antimicrobials against the four major mycoplasma species were entered into a database. The maximum and minimum data for each time period were compared for tiamulin, tylosin, oxytetracycline, lincomycin and enrofloxacin.
 

From the 20 references and reports, 13 were from before 1990 and seven from 1990 and after. There was information on 241 isolates of MG, 105 of MS, 28 of M. meleagridis (MM) and 111 of
M. iowae (MI). The comparative data for the four mycoplasma species are summarized in the tables below.
 

 
 

Mycoplasma gallisepticum, MIC ranges (µg/ml) by time period (no. of isolates)
Antimicrobial
1975-1989 (175)
1990-2000 (66)
Tiamutin® (tiamulin)
0.0039-0.78
0.006-0.39
Tylosin
0.5
0.05-0.5
Oxytetracycline
0.5
0.1-0.5
Lincomycin
0.025
0.0025-50
Enrofloxacin
0.11
0.025->100

 
 

Mycoplasma synoviae, MIC ranges (µg/ml) by time period (no. of isolates)
Antimicrobial
1975-1989 (53)
1990-2000 (52)
Tiamutin® (tiamulin)
0.031-1.0
0.006-0.5
Tylosin
0.015-75
0.006-50
Oxytetracycline
0.06-0.08
0.025-100
Lincomycin
0.31-6.0
0.05-1.56
Enrofloxacin
0.1-1.0
0.025-1.56

 
 

Mycoplasma meleagridis, MIC ranges (µg/ml) by time period (no. of isolates)
Antimicrobial
1975-1989 (17)
1990-2000 (11)
Tiamutin® (tiamulin)
0.03-1.0
0.025-3.13
Tylosin
0.015-3.0
0.78-50
Oxytetracycline
0.3-5.0
0.05-25
Lincomycin
0.5-5.0
0.05-25
Enrofloxacin
0.015-1.0
0.1-3.13

 
 

Mycoplasma iowae, MIC ranges (µg/ml) by time period (no. of isolates)
Antimicrobial
1975-1989 (25)
1990-2000 (86)
Tiamutin® (tiamulin)
0.015-10
0.006-0.125
Tylosin
0.05-64
0.05-100
Oxytetracycline
1-3
0.025-100
Lincomycin
3-64
0.05-100
Enrofloxacin
0.1-1.0
0.005-1.0

 
 

MG has shown no resistance development to tiamulin over the last 25 years and all 241 isolates could be considered sensitive. In contrast there is resistance development to tylosin, oxytetracycline, lincomycin and borderline resistance to enrofloxacin and this appears to have increased in the last decade.
 

 
 

MS has shown no increase in resistance to tiamulin and almost all of the 105 isolates would be considered sensitive. In contrast, resistance has developed to tylosin and oxytetracycline. Levels of resistance to lincomycin remained low and all strains could be considered sensitive to enrofloxacin.
 

 
 

MM isolates (28) from turkeys showed some slight increase in resistance to tiamulin and enrofloxacin. However, tylosin, oxytetracycline and lincomycin showed a marked increase in resistance development.
 

 
 

MI has developed almost no resistance to tiamulin and enrofloxacin. In the nineties all isolates would be considered sensitive. High levels of resistance have developed to tylosin, oxytetracycline and lincomycin.
 

 
 

Tiamutin - your first choice for mycoplasma control in poultry

Back to the top

Home | Contact | Help | Legal Disclaimer | Privacy Policy
© 2007 Novartis Animal Health Inc.
Please note that not all products listed within this site may be available in all countries.
Also, prescribing information and indications for products may differ from country to country, so please
consult your local veterinarian for local prescribing and any other information you may be interested in.